STERIS plc Insider Trading

STE

Last 12 months

Insiders sold $9.83M and bought nothing on the open market.

13% of the selling was scheduled in advance under 10b5-1 plans. Sr. VP, Gen Counsel, and Sec. John Adam Zangerle sold $3.98M on Nov 11, 2025, 31% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market

−$9.83M

0 buys · 8 sales

Under a 10b5-1 plan

13%

of the value sold

Insiders who bought / sold

0 / 7

executives and directors

Last open-market buy

None

in the last two years

Get an email when STE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 12	Mohsen Sohi Director	SoldNo plan	4,058	$235.78	957K	14%	Form 4
Jun 15	John Adam Zangerle Sr. VP, Gen Counsel, and Sec.	Sold10b5-1 plan	1,419	$209.28	297K	3.9%	Form 4
Jun 4 – 5	Daniel A Carestio President and CEO	Sold10b5-1 plan 2 parts	4,428	$213.82 average	947K	6.5%	Form 4
Jun 2	Richard C Breeden Director	SoldNo plan	1,481	$209.51	310K	2.2%	Form 4
Mar 5	Cynthia L Feldmann Director	SoldNo plan	3,098	$237.21	735K	25%	Form 4
Nov 21, 2025	Julia Madsen Sr. VP and GM, Life Sciences	SoldNo plan 2 parts	5,008	$262.00 average	$1.31M	32%	Form 4
Nov 18, 2025	Renato Tamaro V.P. & Corporate Treasurer	SoldNo plan 3 parts	5,036	$257.55 average	$1.3M	47%	Form 4
Nov 11, 2025	John Adam Zangerle Sr. VP, Gen Counsel, and Sec.	SoldNo plan	15,000	$265.14	$3.98M	31%	Form 4
Oct 6, 2025	Daniel A Carestio President and CEO	Sold10b5-1 plan	159	$241.82	38K	0.3%	Form 4
Aug 20, 2025	Renato Tamaro V.P. & Corporate Treasurer	SoldNo plan	3,204	$249.24	799K	31%	Form 4
Aug 11, 2025	Mohsen Sohi Director	SoldNo plan	4,110	$241.96	994K	16%	Form 4
Aug 11, 2025	Cynthia L Feldmann Director	SoldNo plan	3,495	$241.56	844K	27%	Form 4
Aug 11, 2025	Karen L Burton VP & CAO	SoldNo plan	7,900	$241.73	$1.91M	57%	Form 4
Jun 13, 2025	John Adam Zangerle Sr. VP, Gen Counsel, and Sec.	Sold10b5-1 plan 2 parts	1,978	$241.45 average	478K	5.5%	Form 4
Jun 5, 2025	Daniel A Carestio President and CEO	Sold10b5-1 plan 3 parts	17,626	$242.56 average	$4.28M	26%	Form 4
May 20, 2025	Cary L Majors SVP and President, Healthcare	SoldNo plan 2 parts	12,828	$250.08 average	$3.21M	53%	Form 4
Nov 25, 2024	Cary L Majors SVP and President, Healthcare	SoldNo plan	1,682	$217.32	366K	13%	Form 4

Aug 12No plan
Mohsen Sohi
Director · sold 4,058 at $235.78
957K
14% of stake
Jun 1510b5-1 plan
John Adam Zangerle
Sr. VP, Gen Counsel, and Sec. · sold 1,419 at $209.28
297K
3.9% of stake
Jun 4 – 510b5-1 plan
Daniel A Carestio
President and CEO · sold 4,428 at avg $213.82
947K
6.5% of stake
Jun 2No plan
Richard C Breeden
Director · sold 1,481 at $209.51
310K
2.2% of stake
Mar 5No plan
Cynthia L Feldmann
Director · sold 3,098 at $237.21
735K
25% of stake
Nov 21, 2025No plan
Julia Madsen
Sr. VP and GM, Life Sciences · sold 5,008 at avg $262.00
$1.31M
32% of stake
Nov 18, 2025No plan
Renato Tamaro
V.P. & Corporate Treasurer · sold 5,036 at avg $257.55
$1.3M
47% of stake
Nov 11, 2025No plan
John Adam Zangerle
Sr. VP, Gen Counsel, and Sec. · sold 15,000 at $265.14
$3.98M
31% of stake
Oct 6, 202510b5-1 plan
Daniel A Carestio
President and CEO · sold 159 at $241.82
38K
0.3% of stake
Aug 20, 2025No plan
Renato Tamaro
V.P. & Corporate Treasurer · sold 3,204 at $249.24
799K
31% of stake
Aug 11, 2025No plan
Mohsen Sohi
Director · sold 4,110 at $241.96
994K
16% of stake
Aug 11, 2025No plan
Cynthia L Feldmann
Director · sold 3,495 at $241.56
844K
27% of stake
Aug 11, 2025No plan
Karen L Burton
VP & CAO · sold 7,900 at $241.73
$1.91M
57% of stake
Jun 13, 202510b5-1 plan
John Adam Zangerle
Sr. VP, Gen Counsel, and Sec. · sold 1,978 at avg $241.45
478K
5.5% of stake
Jun 5, 202510b5-1 plan
Daniel A Carestio
President and CEO · sold 17,626 at avg $242.56
$4.28M
26% of stake
May 20, 2025No plan
Cary L Majors
SVP and President, Healthcare · sold 12,828 at avg $250.08
$3.21M
53% of stake
Nov 25, 2024No plan
Cary L Majors
SVP and President, Healthcare · sold 1,682 at $217.32
366K
13% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch STE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with STE

CompareIntrinsic value

EWEdwards Lifesciences Corporation

$99.37+4.39%60

ALGNAlign Technology, Inc.

$164.90+8.79%66

ZBHZimmer Biomet Holdings, Inc.

$110.15+13.49%66

ENOVEnovis Corporation

$24.42+16.90%42

MSAMsa Safety Inc.

$177.60+2.03%75

BBLGBone Biologics Corporation

$0.35-1.98%21

ISRGIntuitive Surgical Inc.

$482.10+9.38%83

AVNSAvanos Medical Inc.

No recent price12

Held by ETFs

STE is in 240 US ETFs. The largest of them, with STE's weight in each:

Spot a number that looks wrong? Check it in STE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing STE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.